SyntheticMR AB (publ) engages in the development and marketing of imaging and software solutions for magnetic resonance imaging (MRI) in Sweden and internationally. Its SyMRI solutions measures the body’s tissue properties and generates various contrast weighted images, biomarker segmentations, and quantitative data with a single MR sequence. The company also offers SyMRI NEURO includes contrast weighted images, as well as biomarker segmentation, volumetric measurements of brain tissues and parametric maps that provide objective decision support for the diagnosis and follow-up of patients; SyMRI MSK provides quantitative T1, T2, and PD maps, as well as multiple contrast-weighted images; and MAGiC, a customer-specific version of SyMRI IMAGE. In addition, it provides SyMRI MSK Spine and SyMRI Knee that offers a solution in obtaining anatomical information from a single MRI sequence. It sells its products to the United States, Japan, India, Germany, and South Korea. The company was incorporated in 2007 and is headquartered in Linköping, Sweden.
Metrics to compare | SYNTH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSYNTHPeersSector | |
---|---|---|---|---|
P/E Ratio | −50.3x | 12.0x | −0.5x | |
PEG Ratio | 0.02 | −0.17 | 0.00 | |
Price/Book | 11.6x | 2.2x | 2.6x | |
Price / LTM Sales | 28.1x | 2.1x | 3.2x | |
Upside (Analyst Target) | −12.8% | 17.9% | 45.7% | |
Fair Value Upside | Unlock | 16.1% | 8.6% | Unlock |